# Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

> **NCT00533572** · — · TERMINATED · sponsor: **Stanford University** · enrollment: 1 (actual)

## Conditions studied

- Epidermolysis Bullosa Dystrophica

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00533572
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study was suspended until FDA approved the IND. Study has since been terminated and a new screening process has been implemented.
- **Last updated:** 2015-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533572, "Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00533572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*